Glycopyrronium + formoterol (Bevespi Aerosphere)

Status:: Green
Decision Date:: June 2021

Comments

GREEN 2nd line LABA/LAMA:

Bevespi aerosphere (MDI) (Decision date - June 2021)

See local COPD guidance. Choice should be based on patient ability to tolerate and use inhaler device.